Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Peptid
Kurzübersicht für Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) Peptid (ABIN936170)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- YPHPAYPMPF ITTILGGLYP SKSILLSGTV LPSAQRFHIN LCSGNHIAFH
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LGALS9 antibody,
Alternative Names: LGALS9 control peptide, LGALS9 antibody Blocking Peptide, Anti-LGALS9 Blocking Peptide, Lectin Galactoside-Binding Soluble 9 Blocking Peptide, Galectin 9 Blocking Peptide, ECALECTIN Blocking Peptide, HUAT Blocking Peptide, MGC117375 Blocking Peptide, MGC125973 Blocking Peptide, MGC125974 Blocking Peptide, galectin-9 Blocking Peptide, LGALS9, LGALS-9, LGALS 9, LGALS-9 Blocking Peptide, LGALS 9 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
-
Hintergrund
- The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS9 is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency.
-
Molekulargewicht
- 39 kDa
Target
-